Literature DB >> 16034720

Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes.

D Kraus1, J Jäger, B Meier, M Fasshauer, J Klein.   

Abstract

Aldosterone is a mineralocorticoid hormone that regulates blood pressure and salt/water balance. Increased aldosterone levels are found in states of disturbed energy balance such as the metabolic syndrome. Adipose tissue has been recognized to play a pivotal role in the regulation of energy homeostasis. We investigated direct aldosterone effects on brown adipocyte function. Aldosterone dose-dependently inhibited expression of uncoupling protein-1 (UCP-1) by 30% (p < 0.01). Furthermore, aldosterone dose-dependently impaired insulin-induced glucose uptake by about 25% (p < 0.01). On a transcriptional level, mRNA of the proinflammatory adipokines leptin and monocyte chemoattractant protein-1 (MCP-1) was increased by 5,000% and 40%, respectively, by aldosterone exposure (p < 0.05). This study demonstrates that aldosterone directly impacts on major adipose functions including stimulation of proinflammatory adipokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034720     DOI: 10.1055/s-2005-870240

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  32 in total

Review 1.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.

Authors:  Jennifer N Cooper; Ping Tepper; Emma Barinas-Mitchell; Genevieve A Woodard; Kim Sutton-Tyrrell
Journal:  Clin Exp Hypertens       Date:  2011-10-18       Impact factor: 1.749

Review 3.  Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.

Authors:  Laura D Kubzansky; Gail K Adler
Journal:  Neurosci Biobehav Rev       Date:  2009-07-22       Impact factor: 8.989

Review 4.  The renin-angiotensin-aldosterone system and glucose homeostasis.

Authors:  James Matthew Luther; Nancy J Brown
Journal:  Trends Pharmacol Sci       Date:  2011-08-29       Impact factor: 14.819

Review 5.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 6.  The ubiquitous mineralocorticoid receptor: clinical implications.

Authors:  Urseline A Hawkins; Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

7.  Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.

Authors:  L J Moran; C Meyer; S K Hutchison; S Zoungas; H J Teede
Journal:  J Endocrinol Invest       Date:  2009-10-15       Impact factor: 4.256

8.  Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines.

Authors:  Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

9.  Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.

Authors:  Guido Lastra; Adam Whaley-Connell; Camila Manrique; Javad Habibi; Alex A Gutweiler; Lama Appesh; Melvin R Hayden; Yongzhong Wei; Carlos Ferrario; James R Sowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-29       Impact factor: 4.310

Review 10.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.